When: Wed December 05, 2012 9:30 am
Organization: New England Venture Capital Association
Location: Voltage Coffee & Art - 295 3rd St., Kendall Square, Cambridge, MA
Stephen Kraus, a partner in the Cambridge, Mass. office, has worked with Bessemer since 2004 and focuses on the healthcare sector.
Steve has been actively involved in Bessemer’s investments in Sirtris Pharmaceuticals (NASDAQ: SIRT, acquired by GlaxoSmithKline); Affymax(NASDAQ: AFFY); Aveo (NASDAQ: AVEO); Alnara, acquired by Eli Lilly; Transave (NASDAQ: INSM);Stromedix, acquired by Biogen Idec, Verastem(NASDAQ: VSTM), and Restore Medical (NASDAQ: REST), acquired by Medtronic. He currently sits on the boards of Verastem, Allena Pharmaceuticals,Alcresta, Ovascience, Liazon and Health Essentials and is actively involved in BVP's investments in Acceleron and Proteon.
Prior to joining Bessemer, Steve was a director at the Ironwood Equity Fund, a growth-stage, private-equity firm, and a management consultant at Bain & Co. In 2002, he served as speechwriter and operations director for the Democratic nominee for governor of Massachusetts.
Steve graduated summa cum laude with a B.A. from Yale University and earned his MBA from Harvard, where he was a Baker Scholar. He serves on the boards of the New England Venture Capital Association (NEVCA), the Achievement Network, and Interise.